Shopping Cart
- Remove All
Your shopping cart is currently empty
DPI-3290 is a specific agonist of opioid receptors (Ki: 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively) with potent antinociceptive activity. DPI-3290 is one of a series of novel centrally acting agents.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,970 | 8-10 weeks | |
| 50 mg | $2,580 | 8-10 weeks | |
| 100 mg | $3,400 | 8-10 weeks |
| Description | DPI-3290 is a specific agonist of opioid receptors (Ki: 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively) with potent antinociceptive activity. DPI-3290 is one of a series of novel centrally acting agents. |
| Targets&IC50 | μ opioid receptor:0.46 nM, δ opioid receptor:0.18 nM, κ opioid receptor:0.62 nM |
| In vivo | In rats, DPI-3290 (i.v; 0.05 mg/kg) produces a 50% antinociceptive response. |
| Synonyms | Org 41793 |
| Molecular Weight | 487.61 |
| Formula | C30H34FN3O2 |
| Cas No. | 182417-73-8 |
| Relative Density. | 1.161 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.